Marshall Wace
FENC icon

Marshall Wace’s Fennec Pharmaceuticals FENC Stock Holding History

Marshall Wace’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Buy
+138,758
New +$1.13M ﹤0.01% 2007
2026
Q1 		– Sell
-127,693
Closed -$983K – 3352
2025
Q4 		$983K Buy
+127,693
New +$1.05M ﹤0.01% 1945
2023
Q2 		– Sell
-15,066
Closed -$125K – 2614
2023
Q1 		$125K Buy
+15,066
New +$140K ﹤0.01% 2475

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Marshall Wace's FENC Position: Q2 2026 in Review

Marshall Wace opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 138,758 shares worth $1.49M. The stake represents ﹤0.01% of the portfolio and ranks #2007 among its holdings. This is a return to the name: Marshall Wace previously reported a position in FENC as recently as Q4 2025.

Marshall Wace first reported a position in FENC in Q1 2023 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Marshall Wace held 138,758 shares of Fennec Pharmaceuticals worth $1.49M as of Q2 2026.
  • Fennec Pharmaceuticals was a new Marshall Wace position in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2007 holding.
  • Marshall Wace first reported a position in Fennec Pharmaceuticals in Q1 2023 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.